PERIPHERAL ARTERIAL DISEASE

✓ Medically ReviewedDISEASEID: MDBT0175🚨 TRIAGE: URGENTICD-10: I70.2

📖

Definition

CLINICAL DEFINITION

A chronic, progressive atherosclerotic condition characterised by the narrowing or occlusion of the arteries supplying the lower extremities, leading to reduced blood flow, ischaemia, and a spectrum of clinical presentations ranging from asymptomatic disease to intermittent claudication and chronic limb-threatening ischaemia.

IN PLAIN ENGLISH

A condition where the arteries in the legs become narrowed or blocked by fatty deposits, reducing blood flow to the muscles and skin, which can cause pain when walking and, in severe cases, tissue damage or loss.

COMMON MISCONCEPTION / WHAT IT DOES NOT MEAN

Peripheral Arterial Disease is NOT venous insufficiency, peripheral neuropathy, or spinal stenosis, although these conditions can present with similar lower limb symptoms such as leg pain, heaviness, or weakness.

🔤

Word Breakdown

peripher-

=outer boundary or circumference (from Greek 'periphereia')

-al

=pertaining to

Literal Meaning: Disease pertaining to the arteries of the outer regions of the body (extremities)

🏷️

Abbreviations

PAD=Peripheral Arterial Disease — standard clinical abbreviation

ABI=Ankle-Brachial Index — primary non-invasive diagnostic test

CLI=Critical Limb Ischaemia — advanced stage with rest pain or tissue loss

CLTI=Chronic Limb-Threatening Ischaemia — contemporary terminology for end-stage PAD

🔄

Synonyms & Variants

Peripheral Vascular Disease›Lower Extremity Arterial Disease›

🎯

Category-Specific Context

As a chronic vascular disease, PAD represents the peripheral manifestation of systemic atherosclerosis. It is classified clinically by symptom severity (asymptomatic, claudication, chronic limb-threatening ischaemia) and anatomically by the location and extent of arterial lesions (e.g., aortoiliac, femoropopliteal, infrapopliteal).

🏥

Clinical Context & Usage

CLINICAL SETTINGS

Vascular Surgery ClinicCardiology OutpatientGeneral PracticeWound Care CentreEmergency Department

USAGE & DOCUMENTATION NOTES

Often documented as 'PAD' or 'PVD' in problem lists. Severity is frequently documented using the Fontaine or Rutherford classifications. Ankle-brachial index values are recorded as ratios (e.g., 'ABI 0.7 on right'). Revascularisation plans are often described by anatomical segment (e.g., 'femoropopliteal bypass').

🔬

Primary Causes & Pathophysiology

PATHOPHYSIOLOGY

Atherosclerosis is the primary mechanism, involving endothelial dysfunction, lipid accumulation, and inflammatory cell infiltration within the arterial intima. This leads to plaque formation, progressive luminal narrowing, and reduced distal perfusion pressure. During exertion, the metabolic demand of skeletal muscle exceeds the restricted blood supply, causing ischaemia and the accumulation of metabolites like lactate, which manifests as claudication. In advanced disease, resting blood flow becomes insufficient to maintain tissue viability, leading to rest pain, ulceration, and gangrene. Collateral vessel formation may partially compensate for occlusions but is often inadequate during increased metabolic demand or when microvascular disease coexists.

PRIMARY CAUSES

Atherosclerosis

Endothelial injury and lipid deposition leading to intimal plaque formation, calcification, and progressive luminal narrowing of large and medium-sized arteries.

Thromboangiitis obliterans (Buerger's disease)

Non-atherosclerotic segmental inflammatory condition causing thrombosis of small and medium-sized arteries and veins, strongly linked to heavy tobacco use.

Vasculitis

Inflammatory destruction of arterial walls (e.g., Takayasu arteritis, giant cell arteritis) leading to stenosis, occlusion, or aneurysm formation.

Popliteal artery entrapment syndrome

Anomalous anatomical relationship between the popliteal artery and surrounding myofascial structures, causing repetitive mechanical compression and secondary thrombosis or aneurysm.

💊

Drug-Induced Causes

💊 Ergot alkaloids (ergotamine) ↗

Mechanism: Cause intense alpha-adrenergic vasoconstriction and vasospasm, which can precipitate severe ischaemia in patients with underlying arterial disease.

→ Discontinue the offending agent immediately; use vasodilators if vasospasm persists.

💊 Non-vasodilating beta-blockers (historical concern) ↗

Mechanism: May reduce cardiac output and cause unopposed alpha-mediated peripheral vasoconstriction, potentially exacerbating claudication symptoms in severe PAD.

→ Use cardioselective or vasodilating beta-blockers (e.g., nebivolol, bisoprolol) if beta-blockade is indicated for concurrent coronary artery disease or heart failure; do not withhold for mild PAD.

🌍

Epidemiology

Prevalence:Affects approximately 5–10% of adults over 65 years globally, with prevalence increasing to over 20% in those over 80. Global estimates suggest over 230 million people are living with PAD, with the highest absolute burden in low- and middle-income countries.

Age Group:Primarily affects adults over 50 years of age, with incidence and severity increasing significantly with advancing age. Premature onset is seen in patients with diabetes, heavy smoking, or chronic kidney disease.

Sex Predilection:Equal

Geographic Distribution:Higher age-adjusted prevalence in high-income countries due to aging populations and historical lifestyle factors, but the absolute number of cases is highest in low- and middle-income regions. Regional variations are heavily influenced by local smoking prevalence, diabetes rates, and access to preventive care.

Red Flags & Triage ★

TRIAGE LEVEL

🚨 URGENT

DO NOT MISS — LIFE-THREATENING PRESENTATIONS

Sudden onset of the 6 Ps (Pain, Pallor, Pulselessness, Paraesthesia, Paralysis, Poikilothermia) indicates acute limb ischaemia, requiring immediate vascular surgery evaluation for potential emergent revascularisation.
A non-healing ulcer or gangrene in a diabetic patient may mask severe underlying PAD; always perform vascular assessment (ABI/TBI) before attributing tissue loss solely to neuropathy.

URGENT EVALUATION TRIGGERS

New onset of ischaemic rest pain in the foot or toes, particularly waking the patient at night and relieved by hanging the foot over the bed
New or rapidly worsening tissue loss (ulceration or gangrene) on the toes, feet, or legs
Sudden, severe leg pain with loss of pulses and neurological deficit (suspected acute limb ischaemia)

Contraindications & Precautions

CONTRAINDICATIONS

Cilostazol in patients with heart failure of any severity (due to decreased survival observed in phosphodiesterase-3 inhibitor trials)
Tight graduated compression stockings in patients with severe arterial insufficiency (ABI < 0.5) as they can further compromise arterial inflow

SPECIAL PRECAUTIONS

Avoid direct application of heating pads or hot water bottles to ischaemic limbs due to impaired sensory perception and high risk of thermal burns
Monitor renal function closely and ensure adequate hydration when using iodinated contrast media for angiography in patients with concomitant chronic kidney disease
Prescribe supervised exercise programmes with caution in patients with unstable angina or severe aortic stenosis

Complications

DOWNSTREAM CLINICAL COMPLICATIONS

Chronic limb-threatening ischaemia (CLTI) — progression to rest pain
non-healing ulcers
and tissue necrosis
Acute limb ischaemia — sudden arterial thrombosis or embolism causing rapid limb threat
Major amputation — required for unsalvageable gangrene or overwhelming infection
Major adverse cardiovascular events (MACE) — high risk of concurrent myocardial infarction and stroke due to systemic atherosclerosis

🔀

Confused With (LASA & DDx) ★

LEXICAL (LASA) — SIMILAR NAMES

Peripheral Venous Disease

Often confused by patients and non-specialists; venous disease involves valve incompetence and pooling of blood (causing oedema and stasis changes), whereas PAD involves arterial narrowing and reduced inflow.

Peripheral Neuropathy

Both can cause foot pain and ulcers; neuropathy is nerve-related (often burning/tingling, worse at night, preserved pulses), while PAD is vascular (claudication, dependent rubor, diminished pulses).

CLINICAL DIFFERENTIAL DIAGNOSES (DDx)

Spinal Stenosis (Neurogenic Claudication)

Key Distinguishing Feature: Pain is often positional, worsened by standing or lumbar extension, and relieved by leaning forward or sitting; pedal pulses and ABI are normal.

Chronic Venous Insufficiency

Key Distinguishing Feature: Presents with aching, heaviness, and oedema that worsens with prolonged standing and improves with elevation; associated with varicose veins, haemosiderin staining, and normal arterial pulses.

Osteoarthritis

Key Distinguishing Feature: Joint pain worsened by movement and weight-bearing, but not strictly related to a specific walking distance or relieved promptly by rest; peripheral pulses are intact.

💎

Clinical Pearls

💎

PAD is a marker of systemic atherosclerosis; patients have a significantly higher risk of myocardial infarction and stroke than of limb loss. Cardiovascular risk reduction (statins, antiplatelets, BP control) is the primary medical intervention.

💎

An ABI > 1.30 or 1.40 suggests non-compressible, calcified vessels, commonly seen in diabetes and chronic kidney disease. In these cases, Toe-Brachial Index (TBI) or pulse volume recordings are required for accurate assessment.

💎

Supervised exercise therapy is a first-line treatment for intermittent claudication and has been shown to improve walking distance as effectively as some endovascular interventions.

💎

Statins are indicated for all patients with PAD, regardless of baseline cholesterol levels, to stabilise plaques and reduce cardiovascular mortality.

📝

Example Usage & SOAP

CLINICAL SENTENCE

"The patient is a 68-year-old male with a history of smoking and type 2 diabetes presenting with bilateral calf claudication at 100 metres and an ankle-brachial index of 0.65 on the right."

IN A SOAP NOTE

S: 72-year-old female reports progressive right calf pain occurring after walking 2 blocks, relieved by 5 minutes of rest. Denies rest pain or colour changes. O: Right femoral pulse 2+, popliteal 1+, dorsalis pedis 1+, posterior tibial trace. Capillary refill 4 seconds. Right ABI 0.72. Skin intact, mild hair loss on toes. A: Right lower extremity intermittent claudication secondary to peripheral arterial disease. High cardiovascular risk. P: 1. Initiate high-intensity statin and low-dose aspirin. 2. Prescribe supervised exercise programme. 3. Smoking cessation counselling. 4. Referral to vascular surgery for duplex ultrasound and consideration of revascularisation if symptoms progress.

DIFFERENTIAL DIAGNOSIS CONTEXT

Differential for exertional leg pain: (1) Vascular claudication (predictable distance, relieved by rest, abnormal ABI); (2) Neurogenic pseudoclaudication (positional, relieved by lumbar flexion, normal ABI); (3) Musculoskeletal (osteoarthritis, chronic exertional compartment syndrome); (4) Venous claudication (aching, bursting sensation, associated with severe venous hypertension).

📊

Classifications & Scoring

GRADING SYSTEM

Fontaine Classification

Stages PAD from I (asymptomatic) to IIa (mild claudication), IIb (moderate to severe claudication), III (ischaemic rest pain), and IV (ulcers or gangrene).

GRADING SYSTEM

Rutherford Classification

Categorises PAD into grades 0-3 and categories 0-6, ranging from asymptomatic (0) to severe claudication (3), ischaemic rest pain (4), minor tissue loss (5), and major tissue loss (6).

GRADING SYSTEM

SVS WIfI Classification

Society for Vascular Surgery classification for threatened limbs, grading Wound, Ischaemia, and foot Infection to predict amputation risk and guide revascularisation.

📈

Prognosis

SHORT-TERM OUTCOME

With optimal medical therapy and risk factor modification, short-term limb salvage rates for claudication are excellent. However, the 1-year risk of major adverse cardiovascular events (MACE) is significantly elevated (approximately 5–10%).

LONG-TERM PROGNOSIS

The 5-year mortality rate for patients with symptomatic PAD is approximately 20–30%, primarily driven by concurrent coronary and cerebrovascular disease. For patients presenting with chronic limb-threatening ischaemia, 1-year mortality can exceed 25% without successful revascularisation and aggressive medical optimisation.

📚

References & Coding

ICD-10 DIAGNOSTIC CODE

I70.2

LITERATURE CITATIONS & GUIDELINES

[1]Gerhard-Herman MD et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease. Circulation. 2017;135(12):e726-e779.

[2]Aboyans V et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases. Eur Heart J. 2018;39(9):763-816.

[3]Norgren L et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(1 Suppl):S1-75.

MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current clinical diagnostic criteria, institutional protocols, and official guidelines. Medobo is not responsible for clinical decisions made based on this content.

PERIPHERAL ARTERIAL DISEASE

Definition

Word Breakdown

Abbreviations

Synonyms & Variants

Category-Specific Context

Clinical Context & Usage

Primary Causes & Pathophysiology

Drug-Induced Causes

Epidemiology

Red Flags & Triage ★

DO NOT MISS — LIFE-THREATENING PRESENTATIONS

URGENT EVALUATION TRIGGERS

Contraindications & Precautions

CONTRAINDICATIONS

SPECIAL PRECAUTIONS

Complications

DOWNSTREAM CLINICAL COMPLICATIONS

Confused With (LASA & DDx) ★

Clinical Pearls

Example Usage & SOAP

Classifications & Scoring

Fontaine Classification

Rutherford Classification

SVS WIfI Classification

Prognosis

SHORT-TERM OUTCOME

LONG-TERM PROGNOSIS

Related Terms

References & Coding